RNA Leaders Europe, Basel, March 2023 - RNA, mRNA, RNAi and Oligonucleotide Therapeutics

Temi della conferenza
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of therapeutics targeting or made of RNA with the view to developing a high-level conference. And so, RNA Leaders was born.

Professional congress organizer (PCO)
LSX - partnering for Life Science eXecutives

Annotazioni
LinkedIn: https://go.evvnt.com/1430930-3?pid=4832

Speakers: Andreas Kuhn, SVP RNA Biochemistry and Manufacturing, BioNTech, Paul Nioi, VP Discovery and Translational Research, Alnylam, and more.

https://go.evvnt.com/1430930-2?pid=4832

Mr. Marketing Team